The common medical devices don’t work as well for Black patients. The FDA is now trying to do something about it.
The FDA warned the nation about the growing vulnerability of the medical device supply chain and its effects on public health, particularly among pediatric patients, in a Jan. 16 news release.
Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...
The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...
The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device ...
Our FDA/Food, Drug & Device and Health Care teams discuss new guidance from the Food and Drug Administration (FDA) on federal ...
A Food and Drug Administration (FDA) draft guidance would require manufacturers of pulse oximeters to gather far more ...
The U.S. Food and Drug Administration has sent a warning letter to Marlborough, Mass.-based medical technology company ...
Here are three recent recalls reported to the FDA: ...
FDA Medical Device Regulation Over the Use of AI in Clinical Trials As FDA noted in the JAMA article, artificial intelligence and machine learning (AI/ML) have many potential uses in clinical ...
By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...
Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even ...